News > Covaxin neutralises both Alpha, Delta variants of Covid-19: US top health institute

Covaxin neutralises both Alpha, Delta variants of Covid-19: US top health institute

The National Institute of Health (NIH) in the United States has found that Bharat Biotech's COVAXIN vaccine generates antibodies that effectively neutralize both Alpha and Delta variants of COVID-19.

The institute said that an adjuvant developed with funding from the NIH has contributed to the success of the "highly efficacious" COVAXIN COVID-19 vaccine.